The contribution of RBM20 truncating variants to human cardiomyopathy

Insights

Truncating variants in RBM20 (RBM20tvs) contribute to arrhythmogenic dilated cardiomyopathy (DCM) but cause milder disease. These RBM20tvs show reduced lifetime disease penetrance compared to other truncating variants.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Etiology of Cardiomyopathies

Background:

  • Dilated cardiomyopathy (DCM) diagnosis increasingly relies on genetic testing.
  • Missense variants in RBM20 are known to cause highly penetrant arrhythmogenic DCM.
  • The clinical significance of truncating RBM20 variants (RBM20tvs) in DCM remains unclear.

Purpose of the Study:

  • To assess the contribution of RBM20tvs to the development of DCM.
  • To evaluate the natural history and penetrance of RBM20tvs in an international cohort.
  • To compare RBM20tvs DCM with RBM20 missense variants and other truncating variants.

Main Methods:

  • Assembled an international cohort of DCM patients with RBM20 variants.
  • Utilized genome-first UK Biobank data for analysis.
  • Assessed etiologic fraction, natural history, and penetrance of RBM20tvs.

Main Results:

  • RBM20tvs had a modest etiologic fraction in arrhythmogenic DCM.
  • Patients with RBM20tvs DCM presented later and had less family history of cardiac events compared to RBM20 missense variant carriers.
  • No significant difference in major heart failure or arrhythmia events, but reduced lifetime hazard in RBM20tvs DCM.
  • Lower incidence of cardiomyopathy, heart failure, or major ventricular arrhythmia in UK Biobank participants with RBM20tvs versus T-box transcription factor T (TTNtvs).

Conclusions:

  • RBM20tvs contribute to arrhythmogenic DCM phenotypes.
  • RBM20tvs confer milder disease severity and reduced lifetime penetrance compared to RBM20 missense variants.
  • Consider potential additive interactions of RBM20tvs with other variants in DCM patients and families.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
53
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.0K